Questions for Medicare in outbreak

October 19, 2012 by Ricardo Alonso-zaldivar
In this May 15, 2012 file photo, Health and Human Services Secretary Kathleen Sebelius speaks in Bethesda, Md. Medicare, overseen by Sebelius' department, is coming under scrutiny in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply. (AP Photo/Jose Luis Magana, File)

(AP)—Questions are being raised about Medicare in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply.

The for seniors long ago flagged compounded drugs manufactured without oversight as safety risks. The outbreak that has sickened more than 250 people nationally has been linked to an injectable steroid from a Massachusetts compounding pharmacy.

In 2007, Medicare revoked coverage of compounded inhaler drugs for lung disease, citing safety reasons.

But Medicare doesn't seem to have consistently used its power to deny payment, and critics say that enables the compounding industry to flourish.

Sen. Charles Grassley says Medicare has some explaining to do. The Iowa Republican says every avenue for preventing another crisis must be explored.

Explore further: Medicare prescription premiums unchanged for 2012

shares

Related Stories

2nd firm agrees to temporary shutdown in outbreak

October 10, 2012

(AP)—A Massachusetts company run by the same executives who operated a specialty pharmacy linked to a fatal meningitis outbreak has agreed to temporarily shut down for inspection by state and federal regulators.

Recommended for you

Higher intelligence score means better physical performance

August 14, 2015

New research reveals a distinct association between male intelligence in early adulthood and their subsequent midlife physical performance. The higher intelligence score, the better physical performance, the study reveals. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.